GlucoTrack Price to Free Cash Flow Ratio 2011-2025 | GCTK
Historical price to free cash flow ratio values for GlucoTrack (GCTK) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| GlucoTrack Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-15 | 5.45 | 0.00 | |
| 2025-03-31 | 10.50 | $-1,583.82 | 0.00 |
| 2024-12-31 | 447.60 | $-2,285.25 | 0.00 |
| 2024-09-30 | 2892.00 | $-2,753.66 | 0.00 |
| 2024-06-30 | 2412.00 | $-2,334.33 | 0.00 |
| 2024-03-31 | 1986.00 | $-2,099.64 | 0.00 |
| 2023-12-31 | 1572.00 | $-1,887.96 | 0.00 |
| 2023-09-30 | 1578.00 | $-1,442.80 | 0.00 |
| 2023-06-30 | 2070.00 | $-1,226.64 | 0.00 |
| 2023-03-31 | 2040.00 | $-1,459.75 | 0.00 |
| 2022-12-31 | 8460.00 | $-1,442.54 | 0.00 |
| 2022-09-30 | 11940.00 | $-1,459.52 | 0.00 |
| 2022-06-30 | 15510.00 | $-1,570.50 | 0.00 |
| 2022-03-31 | 21840.00 | $-1,589.24 | 0.00 |
| 2021-12-31 | 25020.00 | $-1,461.06 | 0.00 |
| 2021-09-30 | 34800.00 | $-1,444.44 | 0.00 |
| 2021-06-30 | 31980.00 | $-1,407.13 | 0.00 |
| 2021-03-31 | 22230.00 | $-1,343.00 | 0.00 |
| 2020-12-31 | 27690.00 | $-1,411.33 | 0.00 |
| 2020-09-30 | 32760.00 | $452.72 | 72.36 |
| 2020-06-30 | 28860.00 | $-740.31 | 0.00 |
| 2020-03-31 | 31200.00 | $-430.07 | 0.00 |
| 2019-12-31 | 46800.00 | $-0.03 | 0.00 |
| 2019-09-30 | 31200.00 | $-1,502.11 | 0.00 |
| 2019-06-30 | 23400.00 | $-0.27 | 0.00 |
| 2019-03-31 | 19500.00 | $-0.39 | 0.00 |
| 2018-12-31 | 39000.00 | $-0.58 | 0.00 |
| 2018-09-30 | 74100.00 | $-0.60 | 0.00 |
| 2018-06-30 | 128700.00 | $-0.68 | 0.00 |
| 2018-03-31 | 152100.00 | $-0.96 | 0.00 |
| 2017-12-31 | 156000.00 | $-0.94 | 0.00 |
| 2017-09-30 | 331500.00 | $-0.97 | 0.00 |
| 2017-06-30 | 156000.00 | $-1.00 | 0.00 |
| 2017-03-31 | 152490.00 | $-1.03 | 0.00 |
| 2016-12-31 | 195000.00 | $-0.93 | 0.00 |
| 2016-09-30 | 196560.00 | $-1.04 | 0.00 |
| 2016-06-30 | 280800.00 | $-1.03 | 0.00 |
| 2016-03-31 | 312000.00 | $-0.84 | 0.00 |
| 2015-12-31 | 273000.00 | $-0.86 | 0.00 |
| 2015-09-30 | 312000.00 | $-0.76 | 0.00 |
| 2015-06-30 | 351000.00 | $-0.68 | 0.00 |
| 2015-03-31 | 382200.00 | $-0.62 | 0.00 |
| 2014-12-31 | 468000.00 | $-0.64 | 0.00 |
| 2014-09-30 | 470340.00 | $-0.64 | 0.00 |
| 2014-06-30 | 546000.00 | $-0.62 | 0.00 |
| 2014-03-31 | 643500.00 | $-0.75 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $0.000B |
| GlucoTrack Inc. is an innovator of GlucoTrack(R), a non-invasive device and digital health platform for measuring glucose levels in people with Type 2 diabetes and prediabetes. GlucoTrack Inc., formerly known as Integrity Applications Inc., is based in Rutherford, NJ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |